CisplatinTreatment OutcomeVaccinationAntineoplastic Combined Chemotherapy ProtocolsAntineoplastic AgentsDrug Resistance, NeoplasmChemotherapy, AdjuvantPlatinumMass VaccinationCell Line, TumorApoptosisOvarian NeoplasmsLung NeoplasmsCombined Modality TherapyDNA DamageDNA AdductsInfluenza VaccinesTumor Suppressor Protein p53Testicular NeoplasmsDoxorubicinCell SurvivalDNA RepairCyclophosphamideEtoposideTumor Cells, CulturedCarcinoma, Non-Small-Cell LungDrug Administration ScheduleDrug SynergismCaspase 3Disease-Free SurvivalSurvival AnalysisImmunization ProgramsCarcinoma, Squamous CellGene Expression Regulation, NeoplasticNeoadjuvant TherapyDose-Response Relationship, DrugMice, NudeVinblastinePaclitaxelNeoplasm StagingCarboplatinSurvival RateProto-Oncogene Proteins c-bcl-2DeoxycytidineCaspasesIfosfamideInfluenza, HumanTaxoidsBreast NeoplasmsImmunization ScheduleXenograft Model Antitumor AssaysRNA, Small InterferingPrognosisHepatitis B VaccinesDNA-Binding ProteinsSignal TransductionMethotrexateKidney Tubules, ProximalCell Proliferationbcl-2-Associated X ProteinPapillomavirus VaccinesTumor Suppressor ProteinsCell CycleCancer VaccinesVomitingNeoplasm Recurrence, LocalSmallpoxVaccinesNeoplasmsKidneyInduction ChemotherapyBlotting, WesternTime FactorsBleomycinVaccines, DNAImmunization, SecondarySmallpox VaccineViral VaccinesGene Knockdown TechniquesBCG VaccineNauseaCell DeathMeasles VaccineAntimetabolites, AntineoplasticAdenocarcinomaAntibodies, ViralProtein-Serine-Threonine KinasesNeutropeniaHead and Neck NeoplasmsTransfectionLeukopeniaInfusions, IntravenousFollow-Up StudiesAntineoplastic Agents, PhytogenicDown-RegulationBacterial VaccinesPneumococcal VaccinesAntineoplastic Agents, AlkylatingCamptothecinReverse Transcriptase Polymerase Chain Reaction